USING RECEPTOR AT-1 ANTAGONIST OR RECEPTOR AT-2 MODULATOR IN TREATMENT OF DISEASES ASSOCIATED WITH INCREASE CONTENT OF AT-1 OR AT-2 RECEPTORS Russian patent published in 2006 - IPC A61K31/41 A61P35/00 

Abstract RU 2271809 C2

FIELD: medicine, oncology.

SUBSTANCE: invention proposes using a medicine valsartan as an antagonist of AT-1 receptors and a modulator of AT-2 receptors in treatment of lung or mammary glands invasive cancer. All carcinomas comprise AT-2 receptors while in hyperplasia of normal epithelial cells AT-2 receptors are localized only. This allows carrying out both diagnosis of malignant tumor development and treatment indicated diseases with valsartan owing to modulation of AT-2 receptors, i. e. based on change of the host biological response for tumor cells.

EFFECT: improved and valuable medicinal properties of medicine agent.

13 tbl, 12 ex

Similar patents RU2271809C2

Title Year Author Number
SOLID PERORAL DOSED OUT FORMS OF VALSARTAN 2005
  • Ballok Dzhillian Rouzmari
  • De-Gasparo Mark
  • Ganter Zabine Marija
RU2361575C2
APPLICATION OF ANGIOTENSIN II RECEPTOR ANTAGONISTS FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION 2006
  • Mann Essika M.
  • Oddu Paskal'
  • Nehar Ehrik Mishel'
RU2345790C2
USING ANGIOTENSIN II RECEPTOR ANTAGONISTS IN TREATMENT OF ACUTE MYOCARDIAL INFARCTION 2000
  • Mann Essika M.
  • Oddu Paskal'
  • Nehar Ehrik Mishel'
RU2298405C2
COMBINATION OF AT LEAST TWO COMPOUNDS CHOSEN FROM GROUPS AT-RECEPTOR ANTAGONISTS OR INHIBITORS OF ACE (ANGIOTENSIN-CONVERTING ENZYME) OR INHIBITORS OF HMG-COA-REDUCTASE (BETA-HYDROXY-BETA-METHYLGLUTARYL-COENZYME-A-REDUCTASE) 2001
  • De-Gasparo Mark
  • Grejvz Kurt S.
RU2298418C2
RENIN INHIBITOR-CONTAINING SYNERGETIC COMPOSITIONS DESIGNATED FOR TREATMENT OF CARDIOVASCULAR DISEASE 2001
  • Kheuitt Uill'Jam
  • Vasella Dan'El' Lusi
  • Uehbb Randi Li
RU2310443C2
SYNTHETIC SCFV ANALOGUE TO 6313/G2 ANTI-ANGIOTENSIN II TYPE 1 RECEPTOR MONOCLONAL ANTIBODY VARIABLE REGIONS 2009
  • Vinson Gavin Pol
  • Barker Stjuart
  • Paddefut Dzhon Richard
RU2512071C2
SYNERGETIC COMBINATIONS CONTAINING RENIN INHIBITOR AND INTENDED FOR TREATMENT OF CARDIOVASCULAR DISEASES 2006
  • Kheuitt Uill'Jam
  • Vasella Dae'El' Lusi
  • Uehbb Randi Li
RU2346703C2
HYPOTENSIVE COMBINATION OF VALSARTAN AND CALCIUM CANAL BLOCKERS 1999
  • Kosparo Mark De
  • Uebb Randi Li
RU2450813C2
HYPOTENSIVE COMBINATION OF VALSARTAN AND CALCIUM CHANNEL BLOCKING AGENT 1999
  • Mark De Kosparo
  • Randi Li Uebb
RU2243768C2
ADMINISTRATION OF RENIN INHIBITORS FOR PREVENTION OR TREATMENT OF DIASTOLIC DYSFUNCTION OR DIASTOLIC HEART FAILURE 2005
  • Feldman Dejvid Luis
  • Luft Fridrikh Kameron
  • Mjuller Dominik Nikolas
  • Uehbb Randi Li
RU2407523C2

RU 2 271 809 C2

Authors

Ballok Dzhillian Rouzmari

De-Gasparo Mark

Ganter Zabina Marija

Dates

2006-03-20Published

1999-12-22Filed